No matches

Dermatology

ADVENT at EADV 2025

Join leading dermatologists for educational symposia on atopic dermatitis, bullous pemphigoid, and chronic spontaneous urticaria at the EADV congress in Paris, France.

MD, MS

Amy Paller +8 more

Past event

17September2025

Location

Paris Expo Porte de Versailles

1 Pl. de la Prte de Versailles 75015 Paris France

Symposium Details

September 17

Bullous Pemphigoid: Insights and Innovations

Experience this engaging presentation by Profs. Donna Culton, Dedee Murrell, and Ulrike Raap, who will highlight the heterogeneous clinical presentations of BP and its burden, delve beneath the surface into how autoimmunity and predominantly type 2 inflammation mediate the disease, and explore the evolving toolbox of current approaches in BP management.

September 19

The Burden of a Lifetime: Can Disease Modification Rewrite the Narrative of AD?

Join Profs. Jean-David Bouaziz, Amy Paller, and Alan Irvine for a dynamic presentation on the multifaceted burden of atopic dermatitis, the evolving concept of disease modification, and the how targeted systemic therapies may help improve long-term patient outcomes.

September 19

Broadening the Lens: Clinical and Immunological Insights That Inform CSU Management

Experience this engaging presentation by Profs. Martin Metz, Elena Netchiporouk, and Jason Hawkes to explore emerging therapies for chronic spontaneous urticaria.

Location

Paris Expo Porte de Versailles

1 Pl. de la Prte de Versailles 75015 Paris France

Check on Google Maps

Speakers

Dermatology

MD, MS

Amy Paller

Walter J. Hamlin Professor and Chair of Dermatology; Professor of Pediatrics at Northwestern University, Evanston, Illinois, US

Dermatology

Alan Irvine

Professor of Dermatology, Trinity College, Dublin, Ireland

Dermatology

MD, PhD

Jean-David Bouaziz

Professor of Dermatology, Université Paris Cité Head of the Department of Dermatology | Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris

Dermatology

MD, PhD

Donna Aline Culton

Professor of Dermatology Associate Director, Clinical Trials Unit Director, Clinical Immunofluorescence Laboratory  University of North Carolina, Chapel Hill Chapel Hill, NC, USA

Dermatology

MD, FAAD, MA, BMBCh, DSc

Dédée Murrell

Professor, Faculty of Medicine Head, Department of Dermatology University of New South Wales St. George Hospital Sydney, Australia

Dermatology

Ulrike Raap

Professor, Department of Experimental Allergology and Immunodermatology, University Department of Dermatology and Allergology, Carl von Ossietzky University of Oldenburg

Dermatology

MD, MSc, FRCPC

Elena Netchiporouk

Assistant Professor, Division of Dermatology, McGill University

Dermatology

MD, MS

Jason Hawkes

Dr. Hawkes is a board-certified dermatologist and Investigator at the Oregon Medical Research Center in Portland, OR and is a current Councilor in the International Psoriasis Council and serves on the NPF Medical Board and Scientific Advisory Committee

Allergy/Immunology

Martin Metz

Professor in the Department of Dermatology and Allergy, Head of Translational Research, and Deputy Head of Clinical Trials | Charité – Universitätsmedizin, Berlin, Germany

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: SwitzerlandChange country/region